Skip to main content
Erschienen in:

29.10.2020 | Thoracic Oncology

Complications and Predictive Factors for Air Leak > 10 Days with Neoadjuvant Chemotherapy Followed by Pleurectomy/Decortication for Malignant Pleural Mesothelioma

verfasst von: Akifumi Nakamura, MD, Nobuyuki Kondo, MD, PhD, Toru Nakamichi, MD, Masaki Hashimoto, MD, PhD, Teruhisa Takuwa, MD, PhD, Seiji Matsumoto, MD, PhD, Kozo Kuribayashi, MD, PhD, Takashi Kijima, MD, PhD, Seiki Hasegawa, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

A few studies have reported the incidence and clinical implications of complications after pleurectomy/decortication (P/D).

Objective

The aim of this study was to assess the details of complications and predictive factors of particularly durable air leak with P/D.

Methods

Data on 163 consecutive patients who underwent neoadjuvant chemotherapy (NAC) followed by P/D for malignant pleural mesothelioma between September 2012 and May 2020 at our institution were retrospectively analyzed. Postoperative complications and the significance of various preoperative risk factors for air leak > 10 days (AL10) to identify the group having a higher risk for particularly durable air leak were investigated. Risk factors for AL10 were sought using univariate and multivariate analyses.

Results

Of 163 patients, 30- and 90-day mortality was 0.6% and 2.5%, respectively. Eighty-four (51.4%) patients experienced grade III or worse postoperative complications according to the Clavien–Dindo classification. The median duration of air leak was 7 postoperative days. AL10 occurred in 53 (32.5%) patients. Fifty-eight patients (35.6%) underwent pleurodesis and five patients (3.1%) underwent reoperation to control the air leak. On univariate analysis, performance status (PS; p = 0.003), prognostic nutritional index (p = 0.01), and pleural effusion (p = 0.04) were statistically significant risk factors for AL10, while on multivariate analysis, PS (odds ratio 4.0, 95% confidence interval 1.3–12.7; p = 0.02) remained the only variable predicted for AL10.

Conclusions

Recent postoperative mortality rates in NAC followed by P/D are quite acceptable. Approximately one in every three patients experienced AL10, and PS may be a risk factor associated with AL10.
Literatur
1.
Zurück zum Zitat Flores RM, Pass HI, Seshan VE, et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 2008; 135:620–6.CrossRef Flores RM, Pass HI, Seshan VE, et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 2008; 135:620–6.CrossRef
2.
Zurück zum Zitat Bölükbas S, Manegold C, Eberlein M, Bergmann T, Fisseler-Eckhoff A, Schirren J. Survival after trimodality therapy for malignant pleural mesothelioma: radical pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy. Lung Cancer 2011; 71:75–81.CrossRef Bölükbas S, Manegold C, Eberlein M, Bergmann T, Fisseler-Eckhoff A, Schirren J. Survival after trimodality therapy for malignant pleural mesothelioma: radical pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy. Lung Cancer 2011; 71:75–81.CrossRef
3.
Zurück zum Zitat Hasegawa S. Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma. Gen Thorac Cardiovasc Surg 2014; 62:516–21.CrossRef Hasegawa S. Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma. Gen Thorac Cardiovasc Surg 2014; 62:516–21.CrossRef
4.
Zurück zum Zitat Hasegawa S, Kondo N, Matsumoto S, et al. Surgical risk and survival associated with less invasive surgery for malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg 2019; 31:301–9.CrossRef Hasegawa S, Kondo N, Matsumoto S, et al. Surgical risk and survival associated with less invasive surgery for malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg 2019; 31:301–9.CrossRef
5.
Zurück zum Zitat Cao C, Tian D, Park J, Allan J, Pataky KA, Yan TD. A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma. Lung Cancer 2014; 83:240–5.CrossRef Cao C, Tian D, Park J, Allan J, Pataky KA, Yan TD. A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma. Lung Cancer 2014; 83:240–5.CrossRef
6.
Zurück zum Zitat Domen A, Berzenji L, Hendriks JMH, et al. Extrapleural pneumonectomy: still indicated? Transl Lung Cancer Res 2019; 7:550–5.CrossRef Domen A, Berzenji L, Hendriks JMH, et al. Extrapleural pneumonectomy: still indicated? Transl Lung Cancer Res 2019; 7:550–5.CrossRef
7.
Zurück zum Zitat Wolf AS, Flores RM. Current treatment of mesothelioma: extrapleural pneumonectomy versus pleurectomy/decortication. Thorac Surg Clin 2016; 26:359–75.CrossRef Wolf AS, Flores RM. Current treatment of mesothelioma: extrapleural pneumonectomy versus pleurectomy/decortication. Thorac Surg Clin 2016; 26:359–75.CrossRef
8.
Zurück zum Zitat Okada M, Mimura T, Ohbayashi C, Sakuma T, Soejima T, Tsubota N. Radical surgery for malignant pleural mesothelioma: results and prognosis. Interact Cardiovasc Thorac Surg 2008; 7:102–6.CrossRef Okada M, Mimura T, Ohbayashi C, Sakuma T, Soejima T, Tsubota N. Radical surgery for malignant pleural mesothelioma: results and prognosis. Interact Cardiovasc Thorac Surg 2008; 7:102–6.CrossRef
9.
Zurück zum Zitat Friedberg JS, Simone CB 2nd, Culligan MJ, et al. Extended pleurectomy-decortication-based treatment for advanced stage epithelial mesothelioma yielding a median survival of nearly three years. Ann Thorac Surg 2017; 103:912–19.CrossRef Friedberg JS, Simone CB 2nd, Culligan MJ, et al. Extended pleurectomy-decortication-based treatment for advanced stage epithelial mesothelioma yielding a median survival of nearly three years. Ann Thorac Surg 2017; 103:912–19.CrossRef
10.
Zurück zum Zitat Sharkey AJ, Tenconi S, Nakas A, Waller DA. The effects of an intentional transition from extrapleural pneumonectomy to extended pleurectomy/decortication. Eur J Cardiothorac Surg 2016; 49:1632–41.CrossRef Sharkey AJ, Tenconi S, Nakas A, Waller DA. The effects of an intentional transition from extrapleural pneumonectomy to extended pleurectomy/decortication. Eur J Cardiothorac Surg 2016; 49:1632–41.CrossRef
11.
Zurück zum Zitat Lang-Lazdunski L, Bille A, Papa S, et al. Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experience. J Thorac Cardiovasc Surg 2015; 149:558–65.CrossRef Lang-Lazdunski L, Bille A, Papa S, et al. Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experience. J Thorac Cardiovasc Surg 2015; 149:558–65.CrossRef
12.
Zurück zum Zitat Bovolato P, Casadio C, Billè A, et al. Does surgery improve survival of patients with malignant pleural mesothelioma? A multicenter retrospective analysis of 1365 consecutive patients. J Thorac Oncol 2014; 9:390–6.CrossRef Bovolato P, Casadio C, Billè A, et al. Does surgery improve survival of patients with malignant pleural mesothelioma? A multicenter retrospective analysis of 1365 consecutive patients. J Thorac Oncol 2014; 9:390–6.CrossRef
13.
Zurück zum Zitat Rena O, Casadio C. Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure. Lung Cancer 2012; 77:151–5.CrossRef Rena O, Casadio C. Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure. Lung Cancer 2012; 77:151–5.CrossRef
14.
Zurück zum Zitat Luckraz H, Rahman M, Patel N, Szafranek A, Gibbs AR, Butchart EG. Three decades of experience in the surgical multi-modality management of pleural mesothelioma. Eur J Cardiothorac Surg 2010; 37:552–6.CrossRef Luckraz H, Rahman M, Patel N, Szafranek A, Gibbs AR, Butchart EG. Three decades of experience in the surgical multi-modality management of pleural mesothelioma. Eur J Cardiothorac Surg 2010; 37:552–6.CrossRef
15.
Zurück zum Zitat Rusch VW, Chansky K, Kindler HL, et al. The IASLC mesothelioma staging project: proposals for the M descriptors and for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for mesothelioma. J Thorac Oncol 2016; 11:2112–9.CrossRef Rusch VW, Chansky K, Kindler HL, et al. The IASLC mesothelioma staging project: proposals for the M descriptors and for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for mesothelioma. J Thorac Oncol 2016; 11:2112–9.CrossRef
16.
Zurück zum Zitat Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 2004; 15:257–60.CrossRef Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 2004; 15:257–60.CrossRef
17.
Zurück zum Zitat Nakamura A, Takuwa T, Hashimoto M, et al. Clinical outcomes with recurrence after pleurectomy/decortication for malignant pleural mesothelioma. Ann Thorac Surg 2020; 109:1537–43.CrossRef Nakamura A, Takuwa T, Hashimoto M, et al. Clinical outcomes with recurrence after pleurectomy/decortication for malignant pleural mesothelioma. Ann Thorac Surg 2020; 109:1537–43.CrossRef
18.
Zurück zum Zitat Hashimoto M, Takeuchi J, Takuwa T, et al. Pleural thickness after neoadjuvant chemotherapy is a prognostic factor in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2019; 157:404–13.CrossRef Hashimoto M, Takeuchi J, Takuwa T, et al. Pleural thickness after neoadjuvant chemotherapy is a prognostic factor in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2019; 157:404–13.CrossRef
19.
Zurück zum Zitat Hasegawa S, Hashimoto M, Kondo N, Miyamoto Y. Non-incisional pleurectomy/decortication. Eur J Cadiothorac Surg 2020; 58:186–7.CrossRef Hasegawa S, Hashimoto M, Kondo N, Miyamoto Y. Non-incisional pleurectomy/decortication. Eur J Cadiothorac Surg 2020; 58:186–7.CrossRef
20.
Zurück zum Zitat Kondo N, Takegawa Y, Hashimoto M, Matsumoto S, Oka S, Hasegawa S. Development of an effective method utilizing fibrin glue to repair pleural defects in an ex vivo pig model. J Cardiothorac Surg 2020; 15:110.CrossRef Kondo N, Takegawa Y, Hashimoto M, Matsumoto S, Oka S, Hasegawa S. Development of an effective method utilizing fibrin glue to repair pleural defects in an ex vivo pig model. J Cardiothorac Surg 2020; 15:110.CrossRef
21.
Zurück zum Zitat Takamochi K, Nojiri S, Oh S, et al. Comparison of digital and traditional thoracic drainage systems for postoperative chest tube management after pulmonary resection: a prospective randomized trial. J Thorac Cardiovasc Surg 2018; 155:1834–1840.CrossRef Takamochi K, Nojiri S, Oh S, et al. Comparison of digital and traditional thoracic drainage systems for postoperative chest tube management after pulmonary resection: a prospective randomized trial. J Thorac Cardiovasc Surg 2018; 155:1834–1840.CrossRef
22.
Zurück zum Zitat Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications five-year experience. Ann Surg 2009; 250:187–96.CrossRef Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications five-year experience. Ann Surg 2009; 250:187–96.CrossRef
23.
Zurück zum Zitat Verma V, Ahern CA, Berlind CG, et al. Treatment of malignant pleural mesothelioma with chemotherapy preceding versus after surgical resection. J Thorac Cadiothorac Surg 2019; 157:758–66.CrossRef Verma V, Ahern CA, Berlind CG, et al. Treatment of malignant pleural mesothelioma with chemotherapy preceding versus after surgical resection. J Thorac Cadiothorac Surg 2019; 157:758–66.CrossRef
24.
Zurück zum Zitat Infante M, Morenghi E, Bottoni E, et al. Comorbidity, postoperative morbidity and survival in patients undergoing radical surgery for malignant pleural mesothelioma. Eur J Cardiothorac Surg 2016; 50:1077–1082.CrossRef Infante M, Morenghi E, Bottoni E, et al. Comorbidity, postoperative morbidity and survival in patients undergoing radical surgery for malignant pleural mesothelioma. Eur J Cardiothorac Surg 2016; 50:1077–1082.CrossRef
25.
Zurück zum Zitat Anegg U, Lindenmann J, Matzi V, Smolle J, Maier A, Smolle-Jüttner F. Efficiency of Fleece-bound sealing (TachoSil) of air leaks in lung surgery: a prospective randomised trial. Eur J Cardiothorac Surg 2007; 31:198–202.CrossRef Anegg U, Lindenmann J, Matzi V, Smolle J, Maier A, Smolle-Jüttner F. Efficiency of Fleece-bound sealing (TachoSil) of air leaks in lung surgery: a prospective randomised trial. Eur J Cardiothorac Surg 2007; 31:198–202.CrossRef
26.
Zurück zum Zitat Wain JC, Kaiser LR, Jojnstone DW, et al. Trial of a novel synthetic Sealant in preventing air leaks after lung resection. Ann Thorac Surg 2001;71:1623–8.CrossRef Wain JC, Kaiser LR, Jojnstone DW, et al. Trial of a novel synthetic Sealant in preventing air leaks after lung resection. Ann Thorac Surg 2001;71:1623–8.CrossRef
27.
Zurück zum Zitat Attaar A, Winger DG, Luketich JD, et al. A clinical prediction model for prolonged air leak after pulmonary resection. J Thorac Cardiovasc Surg 2017; 153:690–9.CrossRef Attaar A, Winger DG, Luketich JD, et al. A clinical prediction model for prolonged air leak after pulmonary resection. J Thorac Cardiovasc Surg 2017; 153:690–9.CrossRef
28.
Zurück zum Zitat Pompili C, Falcoz PE, Salati M, Szanto Z, Brunelli A. A risk score to predict the incidence of prolonged air leak after videoassisted thoracoscopic lobectomy: an analysis from the European Society of Thoracic Surgeons database. J Thorac Cardiovasc Surg 2017; 153:957–65.CrossRef Pompili C, Falcoz PE, Salati M, Szanto Z, Brunelli A. A risk score to predict the incidence of prolonged air leak after videoassisted thoracoscopic lobectomy: an analysis from the European Society of Thoracic Surgeons database. J Thorac Cardiovasc Surg 2017; 153:957–65.CrossRef
29.
Zurück zum Zitat Gilbert S, Maghera S, Seely AJ, et al. Identifying patients at higher risk of prolonged air leak after lung resection. Ann Thorac Surg 2016; 102:1674–9.CrossRef Gilbert S, Maghera S, Seely AJ, et al. Identifying patients at higher risk of prolonged air leak after lung resection. Ann Thorac Surg 2016; 102:1674–9.CrossRef
30.
Zurück zum Zitat Liang S, Ivanovic J, Gilbert S, et al. Quantifying the incidence and impact of postoperative prolonged alveolar air leak after pulmonary resection. J Thorac Cardiovasc Surg 2013; 145:948–54.CrossRef Liang S, Ivanovic J, Gilbert S, et al. Quantifying the incidence and impact of postoperative prolonged alveolar air leak after pulmonary resection. J Thorac Cardiovasc Surg 2013; 145:948–54.CrossRef
31.
Zurück zum Zitat Rivera C, Bernard A, Falcoz PE, et al. Characterization and prediction of prolonged air leak after pulmonary resection: a nationwide study setting up the index of prolonged air leak. Ann Thorac Surg 2011; 92:1062–8.CrossRef Rivera C, Bernard A, Falcoz PE, et al. Characterization and prediction of prolonged air leak after pulmonary resection: a nationwide study setting up the index of prolonged air leak. Ann Thorac Surg 2011; 92:1062–8.CrossRef
32.
Zurück zum Zitat Zhao K, Mei J, Xia C, et al. Prolonged air leak after video-assisted thoracic surgery lung cancer resection: risk factors and its effect on postoperative clinical recovery. J Thorac Dis 2017; 9:1219–25.CrossRef Zhao K, Mei J, Xia C, et al. Prolonged air leak after video-assisted thoracic surgery lung cancer resection: risk factors and its effect on postoperative clinical recovery. J Thorac Dis 2017; 9:1219–25.CrossRef
33.
Zurück zum Zitat Okada S, Shimada J, Kato D, Tsunezuka H, Inoue M. Prolonged air leak following lobectomy can be predicted in lung cancer patients. Surg Today 2017; 47:973–9.CrossRef Okada S, Shimada J, Kato D, Tsunezuka H, Inoue M. Prolonged air leak following lobectomy can be predicted in lung cancer patients. Surg Today 2017; 47:973–9.CrossRef
34.
Zurück zum Zitat Okada S, Shimada J, Teramukai S, et al. Risk stratification according to the prognostic nutritional index for predicting postoperative complications after lung cancer surgery. Ann Surg Oncol 2018; 25:1254–61.CrossRef Okada S, Shimada J, Teramukai S, et al. Risk stratification according to the prognostic nutritional index for predicting postoperative complications after lung cancer surgery. Ann Surg Oncol 2018; 25:1254–61.CrossRef
35.
Zurück zum Zitat Okada S, Shimada J, Kato D, Tsunezuka H, Teramukai S, Inoue M. Clinical significance of prognostic nutritional index after surgical treatment in lung cancer. Ann Thorac Surg 2017; 104:296–302.CrossRef Okada S, Shimada J, Kato D, Tsunezuka H, Teramukai S, Inoue M. Clinical significance of prognostic nutritional index after surgical treatment in lung cancer. Ann Thorac Surg 2017; 104:296–302.CrossRef
36.
Zurück zum Zitat Burt BM, Lee HS, Raghuram AC, et al. Preoperative prediction of unresectability in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2020; 159:2512–20.CrossRef Burt BM, Lee HS, Raghuram AC, et al. Preoperative prediction of unresectability in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2020; 159:2512–20.CrossRef
37.
Zurück zum Zitat Inoue M, Okada S. Correspondence regarding “Is the prognostic nutritional index (PNI) a useful predictive marker for postoperative complications after lung surgery?” by Dr. X Li and J Chen. J Thorac Dis 2019; 11:S472–3.CrossRef Inoue M, Okada S. Correspondence regarding “Is the prognostic nutritional index (PNI) a useful predictive marker for postoperative complications after lung surgery?” by Dr. X Li and J Chen. J Thorac Dis 2019; 11:S472–3.CrossRef
38.
Zurück zum Zitat Singhal S, Ferraris VA, Bridges CR, et al. Management of alveolar air leaksafter pulmonary resection. Ann Thorac Surg 2010; 89:1327–35.CrossRef Singhal S, Ferraris VA, Bridges CR, et al. Management of alveolar air leaksafter pulmonary resection. Ann Thorac Surg 2010; 89:1327–35.CrossRef
Metadaten
Titel
Complications and Predictive Factors for Air Leak > 10 Days with Neoadjuvant Chemotherapy Followed by Pleurectomy/Decortication for Malignant Pleural Mesothelioma
verfasst von
Akifumi Nakamura, MD
Nobuyuki Kondo, MD, PhD
Toru Nakamichi, MD
Masaki Hashimoto, MD, PhD
Teruhisa Takuwa, MD, PhD
Seiji Matsumoto, MD, PhD
Kozo Kuribayashi, MD, PhD
Takashi Kijima, MD, PhD
Seiki Hasegawa, MD, PhD
Publikationsdatum
29.10.2020
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 6/2021
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-09275-y

Neu im Fachgebiet Chirurgie

Antibiotika bei Erwachsenen mit Appendizitis oft ausreichend

Bei etwa zwei Drittel aller Erwachsenen mit akuter Appendizitis könnte eine antibiotische Behandlung ausreichen, wie eine Metaanalyse nahelegt. Die Komplikationsrate war insgesamt gering, auch wenn letztlich doch eine Op. fällig wurde.

Katheterablation bei Vorhofflimmern: Ist frühe Intervention von Vorteil?

Bei Patienten mit Vorhofflimmern scheinen die Therapieergebnisse bezüglich Rezidivfreiheit bei frühzeitiger Katheterablation besser zu sein als bei später erfolgter Ablation. Dafür sprechen Ergebnisse einer aktuellen Registeranalyse. 

Beugt Tranexamsäure schweren Blutungen auch in der Allgemeinchirurgie vor?

Ergebnisse einer Subgruppenanalyse der POISE-3-Studie sprechen dafür, dass eine Prophylaxe mit Tranexamsäure auch bei allgemeinchirurgischen Eingriffen das Risiko für schwere Blutungen senkt.

Höhere Anspannung vor der Op. führt offenbar zu besserem Ergebnis

Ein gewisses Maß an Stress zu Beginn der Op. wirkt sich möglicherweise positiv auf das Gelingen aus, so ein Team aus Boston. Die Komplikationsrate ging unter diesen Umständen signifikant zurück.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.